to Content
Header Image

The future of stem cell research

-
Erwin-Schrödinger-Saal
Plenary / Panel
German and English language
Nobel Laureate in Medicine; Director of the School of Biosciences and Professor of Mammalian Genetics, Cardiff School of Biosciences, Cardiff University
Geschäftsführender Direktor und Leiter der Abteilung Zell- und Entwicklungsbiologie, Max-Planck-Institut für molekulare Biomedizin, Münster
Head, Institute of Medical Genetics; Director, Centre of Pathobiochemistry and Genetics, Medical University of Vienna Chair

FRS, D.Sc. Martin EVANS

Nobel Laureate in Medicine; Director of the School of Biosciences and Professor of Mammalian Genetics, Cardiff School of Biosciences, Cardiff University

 Gained his BA in Biochemistry from Christ College, University of Cambridge in 1963. He received an MA in 1966 and a D.Sc. in 1996. In 1969 he was awarded a Ph.D. degree from University College, London.
 After graduating from Cambridge, he decided on a career studying the genetic control of vertebrate development. His early Ph.D. research led him to explore the use of cultures of mouse teratocarcinoma stem cells in tissue culture systems. He was the first to maintain these cells in tissue culture under conditions where their ability to differentiate was retained indefinitely.
 It was not until 1981, after his return to Cambridge, that he was able to isolate similar cells from normal mouse embryos. Subsequently he and his colleagues demonstrated that these cells which became known as "Embryonic Stem Cells" (ES cells) were able to be used to fully regenerate fertile breeding mice from the tissue culture cells and that these could therefore carry mutations introduced and selected or screened for in culture. This is now the basis of all mouse knockout and targeted genetic manipulation.
 These fundamental developments created new routes to experimental mammalian genetics and hence functional genomics. Since then, Sir Martin, who came to Cardiff University s School of Biosciences in 1999, has been exploiting gene knockout and gene trap methods both for novel discovery and to create animal modes of human disease. From his laboratory came the first demonstration of gene therapy to cure the deficit in Cystic Fibrosis in a whole animal and recently, from a mutated mouse model, insights into the breast cancer gene BRCA2 function.
 Sir Martin has published more than 120 scientific papers. He was elected a Fellow of the Royal Society in 1993 and is a founder Fellow of the Academy of Medical Sciences. In 1993 he was awarded the Walter Cottman Fellowship and the William Bate Hardy Prizes. He was awarded the prestigious Albert Lasker Award for Basic Medical Research in the US in 2001. In 2002 he was awarded an honorary doctorate from Mount Sinai School of Medicine in New York, regarded as one of the world's foremost centres for medical and scientific training.
 Sir Martin is also a member of the Wales Gene Park - which has brought together genetics, life sciences and clinical expertise from across Wales to create a new centre for research of national and international importance which offers state-of-the-art facilities for research, education and commercial exploitation.
 He was knighted in 2004 for his services to medical science and in 2009 was awarded the Gold Medal of The Royal Society of Medicine in recognition of his valuable contribution to medicine.

Dr. Hans SCHÖLER

Geschäftsführender Direktor und Leiter der Abteilung Zell- und Entwicklungsbiologie, Max-Planck-Institut für molekulare Biomedizin, Münster

1984-1986 Wissenschaftlicher Mitarbeiter, Zentrum für Molekulare Biologie Heidelberg (ZMBH) Universität Heidelberg
1985 Ph.D. Molekularbiologie, Zentrum für Molekulare Biologie (ZMBE) der Universität Heidelberg
1986-1988 Forschungsgruppenleiter, Boehringer Mannheim, Forschungszentrum Tutzing
1988-1991 Wissenschaftlicher Mitarbeiter, Max-Planck-Institut für Biophysikalische Chemie, Göttingen
1991-1999 Leiter einer Forschungsgruppe am Europäischen Laboratorium für Molekularbiologie (EMBL), Heidelberg
1994 Habilitation, Ruprecht-Karls-Universität Heidelberg (Venia Legendi in Molekularbiologie)
1999-2004 Professor für Reproduktionsphysiologie an der "School of Veterinary Medicine" und Direktor des "Center of Animal Transgenesis and Germ Cell Research" an der University of Pennsylvania, USA
2000-2004 Inhaber des "Marion Dilley and David George Jones" Lehrstuhls für Reproduktionsmedizin
seit 2004 Außerordentlicher Professor für Biochemie, University of Pennsylvania, School of Veterinary Medicine, Philadelphia, USA
  Vollmitglied der Medizinischen Fakultät der Westfälischen Wilhelms-Universität Münster
  Direktor der Abteilung Zell- und Entwicklungsbiologie, Max-Planck-Institut für molekulare Biomedizin, Münster
seit 2009 Außerordentlicher Professor der Medizinischen Hochschule Hannover (MHH)

Mag. Dr. Markus HENGSTSCHLÄGER

Head, Institute of Medical Genetics; Director, Centre of Pathobiochemistry and Genetics, Medical University of Vienna

1990-1992 Dissertation als Universitätsassistent am Vienna Biocenter, Promotion zum Doktor der Genetik (Auszeichnung)
1993-1994 Postdoc an der Yale University, USA
1995 Universitätsassistent Universität Wien
1997 Habilitation
1998 außerordentlicher Universitätsprofessor
2004 Ausbildungsabschluss: Fachhumangenetiker
2004 Berufung (internationales Berufungsverfahren) zum Universitätsprofessor für Medizinische Genetik an der Medizinischen Universität Wien
seit 2004 Moderator der Medizin- und Wissenschaftssendung "Radiodoktor", ORF, Ö1 Radio
seit 2005 Leiter der Abteilung Genetik, Institut für Kinderwunsch, Lainzerstraße, Wien
2005-2009 Leiter der Abteilung für Medizinische Genetik, Universitätsklinik für Frauenheilkunde, Medizinische Universität Wien
seit 2009 Vorstand des Instituts für Medizinische Genetik, Medizinische Universität Wien
seit 2011 zusätzlich Organisationseinheitsleiter des Zentrum für Pathobiochemie und Genetik der Medizinischen Universität Wien
 - Wissenschaftliche Arbeitsgebiete: Erforschung der humangenetischen Erkrankung Tuberöse Sklerose; Stammzellen aus dem humanen Fruchtwasser; Deregulation von Zelldifferenzierungsprozessen bei humangenetischen Erkrankungen; pränatale und postnatale genetische Routinediagnostik; Genetik in der Reproduktionsmedizin; Bioethik (Schwerpunkt medizinische Genetik und Stammzellforschung).
 - Alleinverantwortliche Verfassung und Leitung der Durchführung einer Vielzahl von Drittmittel-Projekten gefördert durch z.B. Fonds zur Förderung der wissenschaftlichen Forschung (FWF), Marie Curie Research Network (Forschungsförderung der Europäischen Union), Oesterreichische Nationalbank, Bundesministerium für Wissenschaft und Verkehr, Herzfeldersche Familienstiftung, Komission Onkologie der
 Wiener Medizinischen Fakultät, Anton-Dreher-Gedächtnisstiftung, Hochschuljubiläumsstiftung der Stadt Wien.

Technology Forum

show timetable

27.08.2009

08:00 - 10:30Technology brunch of the Tiroler ZukunftsstiftungSocial
11:00 - 11:10Opening by the European Forum AlpbachPlenary
11:10 - 12:00Welcome statementsPlenary
12:00 - 14:00Pathways out of the crisis – new perspectives through research and innovation?Plenary
14:30 - 16:00The future of stem cell researchPlenary
18:00 - 19:30A look at the past – the secrets of our originPlenary
19:30 - 21:30Evening reception hosted by Forschung Austria in cooperation with GFF and BMVITSocial

28.08.2009

07:00 - 13:30Working Group 01: Can we trust in feed and food?Breakout
07:00 - 13:30Working Group 02: An international comparison of research, technology and innovation-policy (RTI) strategiesBreakout
07:00 - 13:30Working Group 03: “Sowing and harvesting” in bio(techno)logical research: From the atomic structure of proteins to the discovery of new drugs and their clinical applicationBreakout
07:00 - 13:30Working Group 04: Biomedical and pharmaceutical engineering – key technologies of the 21st centuryBreakout
07:00 - 13:30Working Group 05: Infratech – a chance in crisisBreakout
07:00 - 13:30Working Group 06: Creativity – fuel for the knowledge society?Breakout
07:00 - 13:30Working Group 07: Creative industries vs. old economy: where is the economy headed?Breakout
07:00 - 13:30Working Group 08: Universities: responsibility for the futureBreakout
07:00 - 13:30Working Group 09: Trust in the future – investment in researchBreakout
07:00 - 13:30Working Group 10: Digital Government – citizens and administration in a conflict areaBreakout
07:00 - 13:30Working Group 11: E-Mobility AustriaBreakout
07:00 - 16:00Junior Alpbach – Science and technology for young peopleBreakout
07:00 - 13:00Ö1 Children’s University Alpbach – Science and technology for kidsBreakout
07:00 - 13:00Technology Workshop: Trend radar of developments in societyBreakout
08:00 - 13:00Special Event: Positioning Austria in the international knowledge areaBreakout
14:30 - 15:45Creativity. How kids learn – learning like kids do?Plenary
16:15 - 18:00Innovative research locations – regions in competitionPlenary

29.08.2009

07:30 - 08:45Can we trust in science? Integrity in scientific researchPlenary
08:45 - 09:30The future of the universe – perspectives for astrophysics and cosmologyPlenary
10:00 - 11:00I-Brain – the technological evolution of the brain?Plenary
11:00 - 11:15Closing statementPlenary
11:15 - 12:00Snack receptionSocial